Oren Levy, MD, PhD
- Assistant Professor of Neurology
Dr. Levy is a neurologist specializing in Movement Disorders, including Parkinson's disease, tremor, dystonia, ataxia, tics, and chorea.
Departmental Appointments
- Department of Neurology
Division of Movement Disorders
Education & Training
- Emory University School of Medicine, GA
- BSc, 1994 Yale University
- MD, 2003 Emory University School of Medicine
- Internship: NewYork-Presbyterian Hospital/Weill Cornell Medical Center
- Residency: NewYork-Presbyterian Hospital/Weill Cornell Medical Center
Links
NIH Grants
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF BIIB054 IN SUBJECTS WITH PARKINSON''S DISEASE (P&S Industry Clinical Trial)
Oct 31 2018 - Oct 31 2023
A RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED,52-WEEK PHASE II STUDY TO EVALUATE THE EFFICACY OF INTRAVENOUS RO7046015 (PRX002) IN PARTICIPANTS WITH EARLY PARKINSON?S DISEASE WITH A 52-WEEK BLINDED EXTENSION (PASADENA) (P&S Industry Clinical Trial)
Nov 30 2017 - Nov 30 2022
TARGETING LEWY BODY SPECIFIC PATHOLOGY USING BIOMARKERS (Federal Gov)
Sep 30 2016 - Aug 31 2021
PARKINSON S FOUNDATION INSTITUTIONAL MOVEMENT DISORDERS TRAINING AWARD (Private)
Jul 1 2019 - Jun 30 2021
PARKINSON S FOUNDATION CENTER OF EXCELLENCE AWARD (Private)
Jul 1 2019 - Jun 30 2020
THE EDMOND J. SAFRA FELLOWSHIP IN MOVEMENT DISORDERS (Private)
Jul 1 2017 - Jun 30 2020
PARKINSON S FOUNDATION INSTITUTIONAL MOVEMENT DISORDERS TRAINING AWARD (Private)
Jun 1 2018 - May 31 2020
MEDTRONIC RESTORATIVE THERAPIES GROUP DBS THERAPY FELLOWSHIP GRANT (Private)
Jul 1 2018 - Jun 30 2019
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE IIA, PARALLEL GROUP, TWO-COHORT STUDY TO DEFINE THE SAFETY, TOLERABILITY, CLINICAL AND EXPLORATORY BIOLOGICAL ACTIVITY OF THE CHRONIC ADMINISTRATI (Private)
Nov 17 2017 - Nov 16 2018
INSTITUTIONAL MOVEMENT DISORDERS FELLOWSHIP AWARD AT COLUMBIA UNIVERSITY (Private)
Jul 1 2016 - Jun 30 2017
PARKINSON S DISEASE FOUNDATION (PDF) RESEARCH CENTER GRANT (Private)
Jul 1 2016 - Jun 30 2017
GADD34 INHIBITION AS A NEUROPROTECTIVE STRATEGY IN PARKINSON DISEASE (Private)
Dec 9 2015 - Dec 8 2016
YES 1: A NOVEL REGULATOR OF PARKIN LEVELS AND NEURONAL SURVIVAL IN PARKINSON DISEASE (Private)
Sep 1 2015 - Aug 31 2016
BALANCING DEATH AND SURVIVAL FACTORS IN PD: THE ROLE OF THE STRESS-RELATED PROTEINS RTP801 AND ATF4 (Federal Gov)
Jul 1 2010 - Jun 30 2016
PARKINSONS DISEASE FOUNDATION RESEARCH CENTER GRANT (Private)
Jul 1 2000 - Jun 30 2016
PARKINSONS DISEASE FOUNDATION RESEARCH CENTER GRANT (Private)
Jul 1 2000 - Jun 30 2015
PARKINSON S DISEASE FOUNDATION RESEARCH CENTE (Private)
Jul 1 2000 - Jun 30 2014
PARKINSON S DISEASE FOUNDATION RESEARCH CENTE (Private)
Jul 1 2000 - Jun 30 2014
MOLECULAR CHARACTERIZATION OF MAPT HAPLOTYPES IN PARKINSON DISEASE (Private)
Jun 1 2013 - May 31 2014
PARKINSON''S DISEASE FOUNDATION RESEARCH CENTER GRANT-CLINICA L CORE (Private)
Jul 1 2000 - Jun 30 2013
